NATCO PHARMA LTD.
업데이트됨

Natco - Short term DARVAS technical trade

178
Natco - Short term technical trade

Fundamentals
MCAP- 28000 Cr
PE - 17.22 < Industry PE of 35.55
PEG Ratio is 1
Debt to Equity is 0.06 and ICR is 99
ROE is 26%, ROCE is 30% ( 5yr ROCE is 15%)
Sales growth is 42%, 5yr Sales growth is 13%
Profit Growth is 100%, 5yr Profit growth is 17%
Promoter holding is 50%
Latest results - excellent

Technicals
CMP - 1566
Bullish - Above EMA 9, 21,63, 200 on daily charts , RSI(14) is 75

Commentary
Based on the Darvas box method, I expect Natco pharma to continue trading up.
With CMP 1571, it has breached its own all time high with good volumes. As you can see the volumes yesterday was well over the 20 day moving average volume. I expect the trend to continue. The below targets are to ride this wave and catch as much upside as possible with little downside risk.

Target : 1689
Stop Loss : 1420 (If already invested) , more conservative stop loss would be 2-3% below CMP

Disclosure 1 - Invested
Disclosure 2 - Not SEBI Registered
Disclosure 3 - This is Not investment advice. Treat it as educational
액티브 트레이드
Natco CMP 1600+

면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.